ID: ALA4788762

Max Phase: Preclinical

Molecular Formula: C47H58N10O8

Molecular Weight: 891.04

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  CCC(NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)C(Cc1ccc2ccccc2c1)NC(=O)[C@@H](N)CC(N)=O)C(N)=O

Standard InChI:  InChI=1S/C47H58N10O8/c1-2-35(42(51)60)53-45(63)38(22-27-15-18-32(58)19-16-27)56-44(62)37(13-7-8-20-48)54-47(65)40(24-31-26-52-36-12-6-5-11-33(31)36)57-46(64)39(55-43(61)34(49)25-41(50)59)23-28-14-17-29-9-3-4-10-30(29)21-28/h3-6,9-12,14-19,21,26,34-35,37-40,52,58H,2,7-8,13,20,22-25,48-49H2,1H3,(H2,50,59)(H2,51,60)(H,53,63)(H,54,65)(H,55,61)(H,56,62)(H,57,64)/t34-,35?,37-,38-,39?,40-/m0/s1

Standard InChI Key:  SMCOYWUQASMHQE-CIXHJIQDSA-N

Associated Targets(Human)

Urotensin II receptor 1388 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 891.04Molecular Weight (Monoisotopic): 890.4439AlogP: 0.71#Rotatable Bonds: 24
Polar Surface Area: 319.74Molecular Species: BASEHBA: 10HBD: 11
#RO5 Violations: 2HBA (Lipinski): 18HBD (Lipinski): 15#RO5 Violations (Lipinski): 3
CX Acidic pKa: 9.42CX Basic pKa: 10.27CX LogP: -0.22CX LogD: -2.01
Aromatic Rings: 5Heavy Atoms: 65QED Weighted: 0.04Np Likeness Score: 0.16

References

1. Bandholtz S,Erdmann S,von Hacht JL,Exner S,Krause G,Kleinau G,Grötzinger C.  (2016)  Urolinin: The First Linear Peptidic Urotensin-II Receptor Agonist.,  59  (22.0): [PMID:27791374] [10.1021/acs.jmedchem.6b00164]

Source